×
SNDL EBITDA 2020-2025 | SNDL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
SNDL ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
SNDL EBITDA 2020-2025 | SNDL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
SNDL ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$225B
Boston Scientific (BSX)
$154.3B
Stryker (SYK)
$144.7B
EssilorLuxottica (ESLOY)
$142.4B
Medtronic (MDT)
$117.9B
Lonza Group Ag (LZAGY)
$48.1B
Haleon (HLN)
$43.6B
ResMed (RMD)
$41.7B
Agilent Technologies (A)
$33.8B
GE HealthCare Technologies (GEHC)
$33.6B
Terumo (TRUMY)
$27.5B
Koninklijke Philips (PHG)
$26.2B
Insulet (PODD)
$22.2B
Zimmer Biomet Holdings (ZBH)
$20.2B
Smith & Nephew SNATS (SNN)
$16B
Baxter (BAX)
$12.6B
Sunny Optical Technology (SNPTF)
$10.8B
Demant (WILYY)
$8.1B
Bio-Rad Laboratories (BIO)
$7.8B
Lantheus Holdings (LNTH)
$3.7B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Prestige Consumer Healthcare (PBH)
$3.2B
Perrigo (PRGO)
$3.2B
ICU Medical (ICUI)
$2.8B
Haemonetics (HAE)
$2.5B
LeMaitre Vascular (LMAT)
$2.2B
Curaleaf Holdings (CURLF)
$2B
Green Thumb Industries (GTBIF)
$1.8B
QuidelOrtho (QDEL)
$1.8B